RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 106 filers reported holding RAPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $469,764 | -33.3% | 28,265 | -25.0% | 0.00% | – |
| Q2 2023 | $704,411 | -1.4% | 37,669 | -3.3% | 0.00% | – |
| Q1 2023 | $714,677 | +3661.5% | 38,947 | +4964.6% | 0.00% | – |
| Q3 2022 | $19,000 | +90.0% | 769 | +36.1% | 0.00% | – |
| Q2 2022 | $10,000 | -92.8% | 565 | -91.1% | 0.00% | – |
| Q1 2022 | $139,000 | -71.6% | 6,321 | -52.6% | 0.00% | – |
| Q4 2021 | $489,000 | +5333.3% | 13,325 | +4608.5% | 0.00% | – |
| Q3 2021 | $9,000 | -35.7% | 283 | -37.1% | 0.00% | – |
| Q2 2021 | $14,000 | -75.9% | 450 | -83.0% | 0.00% | – |
| Q1 2021 | $58,000 | -90.3% | 2,652 | -91.2% | 0.00% | – |
| Q4 2020 | $597,000 | -62.9% | 30,227 | -39.5% | 0.00% | – |
| Q3 2020 | $1,609,000 | +30.8% | 49,975 | +17.9% | 0.00% | – |
| Q2 2020 | $1,230,000 | +333.1% | 42,395 | +217.3% | 0.00% | – |
| Q1 2020 | $284,000 | +6.8% | 13,363 | +38.5% | 0.00% | – |
| Q4 2019 | $266,000 | – | 9,651 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $29,189,000 | 46.08% |
| KPCB XV Associates, LLC | 1,297,063 | $23,671,000 | 43.66% |
| Column Group LLC | 2,680,458 | $48,918,000 | 10.41% |
| Ponoi II Management, LLC | 145,401 | $2,654,000 | 7.21% |
| Euclidean Capital LLC | 432,900 | $7,900,000 | 6.72% |
| AJU IB Investment Co., Ltd. | 99,503 | $1,816,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,023,321 | $18,676,000 | 3.17% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $8,096,000 | 1.62% |
| Ghost Tree Capital, LLC | 165,000 | $3,011,000 | 1.57% |
| Perceptive Advisors | 1,913,791 | $34,927,000 | 1.09% |